The first radiation-free bone and soft tissue imaging method
BoneMRI is a software solution that generates a 3D CT-like image to visualize bone structures derived from an MRI scan.
Why BoneMRI?
Benefits
No radiation
Bone imaging without the need to expose the patient to harmful ionizing radiation.
One-stop-shop
The patient undergoes a single MRI exam and medical practitioners will have all the imaging information they need.
Better diagnostic information
From one exam, bone and soft-tissue images are intrinsically registered for diagnosis and treatment planning with increased confidence.
Integrated in clinical workflow
BoneMRI is automatically reconstructed and forwarded to PACS, seamlessly integrated in the clinical workflow.
Reduce costs
Less imaging exams, less hospital visits, efficient workflows and reduced healthcare costs.
Accelerating the world’s transition to radiation-free medical imaging
Our product
BoneMRI
We unravel hidden information from MR data through a deep understanding of physics and artificial intelligence
Our partners
They trust us
“With BoneMRI, the efficacy of the pre-planning process for my robotic reconstruction cases is greatly improved. It reduces table time and many risks associated with even the most complex spinal surgery.”
Kornelis Poelstra
MD PhD – The Robotic Spine Institute of Las Vegas, USA
“BoneMRI is an important aid in the early diagnosis of diseases that could otherwise not be diagnosed until much later. We can now convert MRI images to CT-like images when there is suspicion of injuries in bone structures.”
Lennart Jans
Professor, Head of Clinics in musculoskeletal radiology University Hospital Ghent, Belgium
Press releases
Latest news
New strategic partnership with Ovidius Medical expands MRIguidance’s European presence
BoneMRI is now available in the UK market.
Ovidius’s expertise is developing market access pathways and commercialising novel medical devices and technologies.
Peter Seevinck appointed as interim CEO at MRIguidance
Peter Seevinck, co-founder and CSO, has been appointed as interim CEO of the company.
He will succeed Roel Raatgever for the foreseeable future and assume responsibilities from January 2022.
BoneMRI is cleared by the FDA
The FDA has cleared BoneMRI for the pelvic region, the first radiation-free bone and soft tissue imaging method.
Healthcare specialists and patients in the US can now benefit from MRIguidance’s software product.
